维普中文期刊产品整合服务
11篇 您的检索式:作者名="STADELMAN K M"
    题名 作者 年代 出处 被引量
1Inhibition of GSK-3~3 activity can result in drug and hormonal re- sistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells 显示文摘Sokolosky M Chappell WH Stadelman K 2014Cell Cycle2014,13,5:1
2Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1pathway in breast cancer:possibilities for therapeutic intervention显示文摘Davis NM Sokolosky M Stadelman K 2014Oncotarget2014,5,13:1
3Inhibition of GSK-313 activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells 显示文摘Sokolosky M Chappell WH Stadelman K 2014Cell Cycle2014,13,5:1
4Deregulation of the EGFR/PI3 K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention 显示文摘Davis N M Sokolosky M Stadelman K 2014Oncotarget2014,5,13:1
5Inhibition of GSK-3beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells显示文摘Sokolosky M Chappell WH Stadelman K 2014Cell Cycle2014,13,5:1
6Deregulation ofthe EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer:possibilities for therapeutic intervention显示文摘Davis NM Sokolosky M Stadelman K 2014Oncotarget2014,5,13:1
7Inhibi-tion of GSK-3P activity can result in drug and hormonalresistance and alter sensitivity to targeted therapy inMCF-7 breast cancer cells 显示文摘Sokolosky M Chappell WH Stadelman K 2014Cell Cycle2014,13,5:1
8Suppression of PTEN function increases breastcancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors显示文摘STEELMAN L S NAVOLANIC P M SOKOLOSKY M L TAYLOR J R LEHMANN B D CHAPPELL W H ABRAMS S L WONG E W STADELMAN K M TERRIAND M LESLIE N R MARTELLI A M STIVALA F LIBRA M FRANKLIN R A MCCUBREY J A 2008Oncogene2008,27,29:1
9Deregulation of the EGFR/PI3K/PTEN/Akt/m TORC1 pathway in breast cancer:possibilities for therapeutic intervention显示文摘Davis NM Sokolosky M Stadelman K 2014Oncotarget2014,5,13:1
10Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells显示文摘Sokolosky M Chappell WH Stadelman K 2014Cell Cycle2014,13,5:1
11Deregulation of the EGFR/PI3K/PTEN/Akt/ mTORC1 pathway in breast cancer: possibilities for therapeutic intervention显示文摘Davis NM Sokolosky M Stadelman K 2014Oncotarget2014,5,13:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费